Association between Serum Gamma-Glutamyl Transferase and Thyroid Cancer in an Ultrasonographically Screened Population
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives: We reported recently a positive correlation between obesity and thyroid cancer in women. Serum gamma-glutamyl transferase (GGT) is regarded as a marker of exposure to environmental pollutants, cancer-causing xenobiotic. This study was conducted to evaluate the mechanism behind the association of obesity with thyroid cancer. We hypothesized serum GGT may be a surrogate for persistent organic pollutants to explain the connection between obesity and thyroid cancer. Materials and Methods: We obtained data from 15,131 subjects who underwent a routine health checkup including thyroid ultrasonography from 2007 to 2008 at the Health Screening and Promotion Center of Asan Medical Center. Suspicious nodules were examined by ultrasonography-guided aspiration. Those with a history of hepatobiliary disease and abnormal result of liver function test were excluded. Serum GGT cut-off points were the 25th, 50th, and 75th sex-specific percentiles. Results: A total of 15,131 subjects (7662 men and 7469 women) were screened by thyroid ultrasonography. Thyroid cancers were diagnosed in 260 patients. After adjustment of age, smoking status, alcohol intake, body mass index, compared with the lowest serum GGT quartile, odds ratios (95% confidence intervals) of risk of thyroid cancer were 0.54 (0.28-0.99) for 2nd quartile, 0.92 (0.56-1.50) for 3rd quartile, and 0.61 (0.34-1.09) for 4th quartile in men. In women, the adjusted odds ratios were 1.06 (0.66-1.72), 1.18 (0.77-1.85), and 0.63 (0.38-1.06) for the 2nd, 3rd, and 4th quartile, respectively. Conclusion: Elevated GGT is not associated with a higher prevalence of thyroid cancer in either gender when evaluated in a routine health checkup setting.
Abstract
Background and Objectives: We reported recently a positive correlation between obesity and thyroid cancer in women. Serum gamma-glutamyl transferase (GGT) is regarded as a marker of exposure to environmental pollutants, cancer-causing xenobiotic. This study was conducted to evaluate the mechanism behind the association of obesity with thyroid cancer. We hypothesized serum GGT may be a surrogate for persistent organic pollutants to explain the connection between obesity and thyroid cancer. Materials and Methods: We obtained data from 15,131 subjects who underwent a routine health checkup including thyroid ultrasonography from 2007 to 2008 at the Health Screening and Promotion Center of Asan Medical Center. Suspicious nodules were examined by ultrasonography-guided aspiration. Those with a history of hepatobiliary disease and abnormal result of liver function test were excluded. Serum GGT cut-off points were the 25th, 50th, and 75th sex-specific percentiles. Results: A total of 15,131 subjects (7662 men and 7469 women) were screened by thyroid ultrasonography. Thyroid cancers were diagnosed in 260 patients. After adjustment of age, smoking status, alcohol intake, body mass index, compared with the lowest serum GGT quartile, odds ratios (95% confidence intervals) of risk of thyroid cancer were 0.54 (0.28-0.99) for 2nd quartile, 0.92 (0.56-1.50) for 3rd quartile, and 0.61 (0.34-1.09) for 4th quartile in men. In women, the adjusted odds ratios were 1.06 (0.66-1.72), 1.18 (0.77-1.85), and 0.63 (0.38-1.06) for the 2nd, 3rd, and 4th quartile, respectively. Conclusion: Elevated GGT is not associated with a higher prevalence of thyroid cancer in either gender when evaluated in a routine health checkup setting.
참고문헌 (26)
- Davies L, "Increasing incidence of thyroid cancer in the United States, 1973-2002", JAMA, 295(18), pp.2164~2167 (2006)
- Chen AY, "Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005", Cancer, 115(16), pp.3801~3807 (2009)
- Blomberg M, "Thyroid cancer in Denmark 1943-2008, before and after iodine supplementation", Int J Cancer, 131(10), pp.2360~2366 (2012)
- Imaizumi M, "Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure", JAMA, 295(9), pp.1011~1022 (2006)
- Preston-Martin S, "Thyroid cancer pooled analysis from 14 case-control studies: what have we learned?", Cancer Causes Control, 14(8), pp.787~789 (2003)
- Iribarren C, "Cohort study of thyroid cancer in a San Francisco Bay area population", Int J Cancer, 93(5), pp.745~750 (2001)
- Renehan AG, "Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies", Lancet, 371(9612), pp.569~578 (2008)
- Han JM, "Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population", Eur J Endocrinol, 168(6), pp.879~886 (2013)
- Lee DH, "Association between serum concentrations of persistent organic pollutants and gamma glutamyltransferase:results from the National Health and Examination Survey 1999-2002", Clin Chem, 52(9), pp.1825~1827 (2006)
- Goldberg DM, "Role of gamma-glutamyl transpeptidase activity in the diagnosis of hepatobiliary disease", Digestion, 12(4-6), pp.232~246 (1975)
- Teschke R, "Induction of hepatic microsomal gamma-glutamyltransferase activity following chronic alcohol consumption", Biochem Biophys Res Commun, 75(3), pp.718~724 (1977)
- Strasak AM, "Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study", Cancer Res, 68(10), pp.3970~3977 (2008)
- WHO Expert Consultation, "Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies", Lancet, 363(9403), pp.157~163 (2004)
- Cooper DS, "Management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 16(2), pp.109~142 (2006)
- Renehan AG, "Obesity and cancer:pathophysiological and biological mechanisms", Arch Physiol Biochem, 114(1), pp.71~83 (2008)
- Wolin KY, "Obesity and cancer", Oncologist, 15(6), pp.556~565 (2010)
- Pisani P, "Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies", Arch Physiol Biochem, 114(1), pp.63~70 (2008)
- Jousilahti P, "Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke", Stroke, 31(8), pp.1851~1855 (2000)
- Lim JS, "A strong interaction between serum gamma-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey", Clin Chem, 53(6), pp.1092~1098 (2007)
- Ruttmann E, "Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults", Circulation, 112(14), pp.2130~2137 (2005)
- Ryu S, "Gammaglutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men", Clin Chem, 53(1), pp.71~77 (2007)
- Lee DH, "Gamma-glutamyltransferase, obesity, and the risk of type 2diabetes: observational cohort study among 20,158 middle-aged men and women", J Clin Endocrinol Metab, 89(11), pp.5410~5414 (2004)
- Franzini M, "Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells", Eur J Cancer, 42(15), pp.2623~2630 (2006)
- Pompella A, "Gamma-glutamyltransferase, redox regulation and cancer drug resistance", Curr Opin Pharmacol, 7(4), pp.360~366 (2007)
- Coles B, "The role of glutathione and glutathione transferases in chemical carcinogenesis", Crit Rev Biochem Mol Biol, 25(1), pp.47~70 (1990)
- Changjiang Xu, "Induction of Phase I, II and III Drug Metabolism", Transport by Xenobiotics, 2005, pp.28(3), 249~268[DOI]